BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17642001)

  • 1. Drug Delivery 2007--New technologies, partnering and strategies for the future.
    Stevenson L
    IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
    [No Abstract]   [Full Text] [Related]  

  • 2. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
    Brown D
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug delivery in biotechnology: present and future.
    Orive G; Hernández RM; Rodríguez Gascón A; Domínguez-Gil A; Pedraz JL
    Curr Opin Biotechnol; 2003 Dec; 14(6):659-64. PubMed ID: 14662398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer nanotechnology: small, but heading for the big time.
    Nat Rev Drug Discov; 2007 Mar; 6(3):174-5. PubMed ID: 17396287
    [No Abstract]   [Full Text] [Related]  

  • 8. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-Generation Pharmaceutical Proteins-EUFEPS Workshop on Optimizing Biotech Medicines.
    Pasut G; Veronese FM
    IDrugs; 2007 Mar; 10(3):162-4. PubMed ID: 17351866
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in technology and business potential of new drug delivery systems.
    Momin M; Disouza J; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):341. PubMed ID: 27365167
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
    Mackonochie M
    IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
    [No Abstract]   [Full Text] [Related]  

  • 14. 9th International drug delivery technologies & deal-making summit.
    Panzner S; Smith PL
    Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying advanced delivery technologies to enable and improve drug development. 8-9 December 2004, London, UK.
    Uchegbu IF
    IDrugs; 2005 Feb; 8(2):112-4. PubMed ID: 15696410
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug Delivery to the Lungs (DDL)--18th conference.
    Seville P
    IDrugs; 2008 Mar; 11(3):161-3. PubMed ID: 18311647
    [No Abstract]   [Full Text] [Related]  

  • 17. SOZO--a Euro-Japanese biotechnology conference.
    Veryard C
    IDrugs; 2005 Jul; 8(7):560-2. PubMed ID: 15973563
    [No Abstract]   [Full Text] [Related]  

  • 18. Pfizer-Pharmacia: the smart fit for the future.
    Wiggins WP
    Expert Opin Investig Drugs; 2003 Jan; 12(1):1-3. PubMed ID: 12517249
    [No Abstract]   [Full Text] [Related]  

  • 19. Medipol: the guardian angel of biologics.
    Laue C; Ruppanner V
    Nanomedicine (Lond); 2006 Aug; 1(2):251-4. PubMed ID: 17716114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser.
    Watkins SM
    Assay Drug Dev Technol; 2004 Aug; 2(4):339-43. PubMed ID: 15357914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.